Security Snapshot

REPLIGEN CORP - Common Stock (RGEN) Institutional Ownership

CUSIP: 759916109

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

471

Shares (Excl. Options)

62,452,444

Price

$163.86

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Type / Class
Equity / Common Stock
Symbol
RGEN on Nasdaq
Shares outstanding
56,095,854
Price per share
$118.32
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
62,452,444
Total reported value
$10,234,084,662
% of total 13F portfolios
0.01%
Share change
+2,680,346
Value change
+$501,267,200
Number of holders
471
Price from insider filings
$118.32
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • RGEN - REPLIGEN CORP - Common Stock is tracked under CUSIP 759916109.
  • 471 institutions reported positions in Q4 2025.
  • 5 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 471 to 328 between Q4 2025 and Q1 2026.
  • Reported value moved from $10,234,084,662 to $4,205,400,621.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 471 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 759916109?
CUSIP 759916109 identifies RGEN - REPLIGEN CORP - Common Stock in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of REPLIGEN CORP - Common Stock (RGEN) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 9.3% $724,772,059 5,198,107 BlackRock, Inc. 31 Mar 2025
PRICE T ROWE ASSOCIATES INC /MD/ 8.2% +35% $753,733,060 +$191,767,488 4,599,860 +34% T. Rowe Price Associates, Inc. 31 Dec 2025
FMR LLC 5.1% $473,742,228 2,891,140 FMR LLC 31 Dec 2025
EDDLEMAN ROY T 4.8% $377,254,217 2,705,689 Roy T. Eddleman Living Trust 31 Dec 2024
Roy T. Eddleman Living Trust 4.8% $443,354,200 2,705,689 Roy T. Eddleman Living Trust 31 Dec 2025

As of 31 Dec 2025, 471 institutional investors reported holding 62,452,444 shares of REPLIGEN CORP - Common Stock (RGEN). This represents 111% of the company’s total 56,095,854 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of REPLIGEN CORP - Common Stock (RGEN) together control 75% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 12% 6,619,271 +7.8% 0.02% $1,084,633,737
VANGUARD GROUP INC 8.9% 4,993,945 -1% 0.01% $818,307,828
PRICE T ROWE ASSOCIATES INC /MD/ 8.2% 4,599,061 +31% 0.08% $753,603,000
FMR LLC 5.1% 2,867,846 +6.6% 0.02% $469,925,204
UNITED CAPITAL FINANCIAL ADVISORS, LLC 4.9% 2,770,862 +0.54% 2.7% $454,033,447
STATE STREET CORP 3.1% 1,719,093 -4.6% 0.01% $281,690,579
CITADEL ADVISORS LLC 2.5% 1,394,252 -17% 0.16% $228,462,133
Bank of New York Mellon Corp 2.4% 1,344,706 +2.2% 0.04% $220,343,507
Invesco Ltd. 2.2% 1,256,439 +44% 0.03% $205,880,096
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 2.2% 1,215,527 0.06% $199,176,255
FRANKLIN RESOURCES INC 2% 1,101,447 +160% 0.04% $180,483,177
RTW INVESTMENTS, LP 1.9% 1,064,000 1.7% $174,347,040
Conestoga Capital Advisors, LLC 1.9% 1,057,975 +11% 2.9% $173,359,783
GEODE CAPITAL MANAGEMENT, LLC 1.8% 1,029,817 -0.25% 0.01% $168,778,619
Point72 Asset Management, L.P. 1.8% 1,006,310 -30% 0.26% $164,893,957
Champlain Investment Partners, LLC 1.8% 1,003,951 -25% 1.7% $164,507,411
ALLIANCEBERNSTEIN L.P. 1.8% 994,869 -9.9% 0.05% $163,019,234
Holocene Advisors, LP 1.7% 961,040 -30% 0.33% $157,476,014
FRED ALGER MANAGEMENT, LLC 1.6% 911,527 +154% 0.59% $149,362,814
DIMENSIONAL FUND ADVISORS LP 1.4% 804,410 +0.61% 0.03% $131,820,884
CONGRESS ASSET MANAGEMENT CO 1.3% 746,306 +241% 0.86% $122,289,701
Stephens Investment Management Group LLC 1.2% 657,111 +9.8% 1.4% $107,674,208
MILLENNIUM MANAGEMENT LLC 1.2% 650,546 -20% 0.08% $106,598,468
T. Rowe Price Investment Management, Inc. 1.2% 646,122 +13% 0.07% $105,874,000
MORGAN STANLEY 1% 570,977 +18% 0.01% $93,560,643

Institutional Holders of REPLIGEN CORP - Common Stock (RGEN) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 35,703,315 $4,205,400,621 +$20,656,799 $117.82 328
2025 Q4 62,452,444 $10,234,084,662 +$501,267,200 $163.86 471
2025 Q3 59,801,741 $7,995,812,322 +$244,121,325 $133.67 449
2025 Q2 58,017,175 $7,215,764,205 +$69,143,795 $124.38 442
2025 Q1 57,398,139 $7,304,074,415 +$139,148,090 $127.24 438
2024 Q4 56,237,230 $8,094,090,864 +$105,844,498 $143.94 427
2024 Q3 55,459,700 $8,245,941,080 +$30,279,223 $148.82 439
2024 Q2 56,044,624 $7,061,943,055 -$124,495,148 $126.06 443
2024 Q1 56,261,991 $10,338,765,280 -$351,039,614 $183.92 480
2023 Q4 58,123,283 $10,446,984,164 +$202,954,749 $179.80 463
2023 Q3 57,114,183 $9,078,983,361 +$388,815,346 $159.01 435
2023 Q2 54,662,151 $7,739,525,912 +$95,572,264 $141.46 441
2023 Q1 53,769,139 $9,050,236,781 +$70,900,818 $168.36 442
2022 Q4 53,510,392 $9,060,023,350 +$399,717,699 $169.31 436
2022 Q3 51,044,970 $9,557,589,432 +$146,390,498 $187.11 424
2022 Q2 50,252,292 $8,165,826,817 +$277,439,901 $162.40 391
2022 Q1 48,677,414 $9,149,179,277 +$200,963,724 $188.09 431
2021 Q4 47,109,897 $12,469,909,891 -$237,031,385 $264.84 488
2021 Q3 47,237,181 $13,643,742,113 +$286,277,453 $288.99 472
2021 Q2 46,326,341 $9,247,532,543 +$156,619,410 $199.62 421
2021 Q1 45,659,995 $8,873,275,638 +$76,902,679 $194.41 453
2020 Q4 45,796,926 $8,774,116,572 +$266,909,562 $191.63 444
2020 Q3 44,707,932 $6,601,225,733 -$40,211,297 $147.54 384
2020 Q2 45,107,923 $5,577,989,614 -$187,234,914 $123.61 363
2020 Q1 46,463,810 $4,483,615,651 +$298,271,944 $96.54 301
2019 Q4 43,538,059 $4,026,527,029 -$117,270,573 $92.50 296
2019 Q3 44,787,098 $3,433,491,573 -$8,489,335 $76.69 295
2019 Q2 44,747,389 $3,843,255,917 +$502,114,798 $85.95 264
2019 Q1 40,224,387 $2,376,319,121 +$32,032,553 $59.08 241
2018 Q4 39,767,674 $2,097,073,822 -$116,566,198 $52.74 237
2018 Q3 41,788,098 $2,317,550,403 +$69,379,349 $55.46 196
2018 Q2 40,579,436 $1,908,570,055 +$106,872,252 $47.04 188
2018 Q1 38,649,161 $1,398,390,226 +$29,165,817 $36.18 181
2017 Q4 37,859,448 $1,373,622,569 +$48,489,524 $36.28 178
2017 Q3 36,449,660 $1,396,445,142 +$28,789,176 $38.32 187
2017 Q2 35,593,025 $1,474,924,268 +$151,642,443 $41.44 197
2017 Q1 32,529,133 $1,144,981,808 +$158,118,910 $35.20 179
2016 Q4 32,263,497 $994,535,738 +$13,422,590 $30.82 180
2016 Q3 31,904,315 $962,738,212 +$47,789,217 $30.19 177
2016 Q2 30,428,990 $832,590,372 +$19,372,010 $27.36 181
2016 Q1 29,619,988 $794,428,927 +$36,143,815 $26.82 180
2015 Q4 28,540,885 $807,342,773 -$43,257,537 $28.29 173
2015 Q3 30,095,607 $838,161,582 -$17,473,045 $27.85 183
2015 Q2 30,306,137 $1,250,670,824 +$37,385,722 $41.27 173
2015 Q1 29,621,574 $898,254,268 +$24,883,359 $30.36 166
2014 Q4 28,861,708 $571,461,773 +$24,816,515 $19.80 158
2014 Q3 28,133,338 $560,134,714 -$3,584,613 $19.91 162
2014 Q2 28,122,228 $640,523,743 +$56,963,037 $22.79 162
2014 Q1 26,217,884 $337,427,505 +$13,060,004 $12.86 132
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .